Candidiasis, Oral

• 

  Subject Areas on Research

  • Acute pulmonary decompensation due to amphotericin B in the absence of granulocyte transfusions. 
  • Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization. 
  • Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. 
  • Chronic mucocutaneous candidiasis. Immunologic studies of three generations of a single family. 
  • Clonal and spontaneous origins of fluconazole resistance in Candida albicans. 
  • Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. 
  • Complications and solutions in presurgical nasoalveolar molding therapy. 
  • Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. 
  • Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis. 
  • Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment. 
  • Effect of smoking on the clinical progression of HIV-1 infection. 
  • Failure to thrive, diarrhea, cough, and oral candidiasis in a three-month-old boy. 
  • Oral candidiasis in cancer patients. 
  • Oral conditions. 
  • Oropharyngeal Candida colonization and human immunodeficiency virus type 1 infection. 
  • Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy. 
  • Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy. 
  • Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID). 
  • Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. 
  • Recurrent infection, chronic diarrhea, and failure to thrive in a seven-month-old infant.